Brain Cancer Patients Display Appropriate Immune Responses and Decreasing Tumor Biomarkers in AIVITA Biomedical’s Phase 2 Clinical Trial

IRVINE, Calif., Oct. 24, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today updated data from its ongoing glioblastoma Phase 2 clinical trial investigating AIVITA’s platform immunotherapy targeting tumor-initiating cells. In approximately 80% of treated patients, sequential blood plasma biomarker analyses have identified the induction of a … Continued

Read More

AIVITA Biomedical Announces Publication Comparing Clinical Outcomes in Patients Treated with AIVITA’s Immunotherapy and Other Immunotherapies

New Comparison Indicates Superior Survival IRVINE, Calif., Oct. 17, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotechnology company specializing in innovative stem cell applications, announced the publication of an article titled “Survival Comparison between Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines and Other Immunotherapies Based on Extent of Disease at the Time of Treatment“ in … Continued

Read More

Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical’s Phase 2 Clinical Trial

IRVINE, Calif., Aug. 14, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today updated clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA’s platform immunotherapy targeting tumor-initiating cells. Blood plasma biomarker analyses have identified a robust immune response and a decrease of tumor biomarkers in … Continued

Read More

AIVITA Biomedical Announces New Clinical Data in Ongoing Phase 2 Brain Cancer Trial

IRVINE, Calif., July 8, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today new clinical data from its ongoing glioblastoma Phase 2 clinical trial, investigating AIVITA’s platform immunotherapy targeting cancer stem cells. Blood plasma biomarker analyses have identified predictive markers of efficacy in seven of eight treated … Continued

Read More

ClearFlow Announces Positive Randomized Controlled Trial Results and Inclusion in ERAS Guideline Recommendations

ANAHEIM, Calif.–(BUSINESS WIRE)– ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results of its PleuraFlow® device were presented at the American Association for Thoracic Surgery (AATS) 99th Annual meeting on May 4 in Toronto, Canada. This new data stems from a trial evaluating the use of ClearFlow’s PleuraFlow®Active Clearance Technology® (ACT®) System … Continued

Read More

AIVITA Biomedical Presents New Clinical Data at 2019 ASCO Annual Meeting

IRVINE, Calif., June 3, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that Chief Medical Officer Dr. Robert O. Dillman presented clinical data on melanoma patients treated with patient-specific vaccines on June 1 at the 55th Annual Meeting of ASCO in Chicago, Illinois. The data is being … Continued

Read More

AIVITA Identifies Mechanism to Enhance Patient Response Rate to Next Generation Cancer Stem Cell Immunotherapy

AIVITA Identifies Mechanism to Enhance Patient Response Rate to Next Generation Cancer Stem Cell Immunotherapy   Findings suggest a combination with checkpoint inhibitors will enhance response rate beyond 72% survival, and facilitate a new Phase 1B approval   IRVINE, Calif., Feb. 12, 2019 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell … Continued

Read More

The Hottest Enterprise Tech Startups to Watch in 2019

  #MariaDB momentum is heating up! @computerworlduk lists #MariaDB as one of the hottest enterprise tech startups in the world. http://ow.ly/I7fU30nAud5   Who are the hottest enterprise tech startups in the world? MariaDB as an open source database contender made the list by Computerworld UK. http://ow.ly/I7fU30nAud5   The hottest enterprise tech startups to watch in 2019   … Continued

Read More

Philips Recognized by Frost & Sullivan for Its Integrated Medication Adherence System, PMAS

Philips Recognized by Frost & Sullivan for Its Integrated Medication Adherence System, PMAS NEWS PROVIDED BY Frost & Sullivan  08:00 ET By connecting patients, pharmacists, caregivers, and providers, the PMAS delivers patient care in a decentralized format SANTA CLARA, Calif., Dec. 5, 2018 /PRNewswire/ — Based on its recent analysis of the North American medication adherence market, Frost … Continued

Read More

ROOT OF SKIN™ Skincare Line Sells Out at Product Launch on QVC Japan

ROOT OF SKIN™ Skincare Line Sells Out at Product Launch on QVC Japan IRVINE, Calif., Nov. 28, 2018 /PRNewswire/ — AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced today that the Company’s revolutionary stem-cell based ROOT OF SKIN™ skincare line sold out at launch on the Japanese home shopping channel QVC Japan. … Continued

Read More